Status:
RECRUITING
OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina
Lead Sponsor:
Korea University Guro Hospital
Collaborating Sponsors:
Abbott
Conditions:
Stable Angina
Coronary Artery Disease
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This study aims to evaluate whether the use of optical coherence tomography (OCT), an advanced intravascular imaging tool, can improve stent implantation results and make it possible to shorten the du...
Detailed Description
Ischemic heart disease (IHD) remains one of the leading causes of death worldwide, and more than 80% of deaths from coronary artery disease (CAD) occur in individuals aged 65 years or older. Elderly p...
Eligibility Criteria
Inclusion
- Patients who undergo PCI using a cobalt-chromium everolimus-eluting stent (CoCr-EES)
- Diagnosis of stable angina
- Ability and willingness to provide written informed consent approved by the Institutional Review Board (IRB), and to comply with the study protocol and clinical follow-up schedule
- Age ≥ 19 years
Exclusion
- Patients diagnosed with acute coronary syndrome (ACS), including unstable angina or acute myocardial infarction
- Contraindications to antiplatelet therapy or OCT imaging
- Presence of lesions with severe stenosis, heavy calcification, or marked vessel tortuosity that prevent passage of a guidewire or catheter
- Patients with previously implanted coronary stents in the target lesion
Key Trial Info
Start Date :
September 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2029
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT07198529
Start Date
September 30 2025
End Date
September 1 2029
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Center, Department of Internal Medicine, Korea University Guro Hospital
Seoul, Gurodong-ro, Guro-gu, South Korea, 148